Doctors answer your questions about RSV
While a potential COVID winter surge and the impending flu season get a lot of attention, doctors are worried about another virus.
Oct 28, 2022
0
35
MeSH tree: D12.776.124.486.485.114.224.060
While a potential COVID winter surge and the impending flu season get a lot of attention, doctors are worried about another virus.
Oct 28, 2022
0
35
Respiratory syncytial virus, more commonly known as RSV, sends thousands of children to the hospital every year in the U.S. But during September and October 2022, health professionals across the country have watched an unprecedented ...
Oct 27, 2022
0
32
Some California children's hospitals are straining under a surge of RSV, a respiratory illness that can cause babies to struggle to breathe.
Oct 26, 2022
0
42
Pediatricians' offices, children's hospitals, urgent care centers and emergency rooms across the United States are being overwhelmed by an early, heavy surge of respiratory syncytial virus (RSV) among infants and young children.
Oct 25, 2022
0
151
Children's hospitals in parts of the U.S. are seeing a surge in a common respiratory illness that can cause severe breathing problems for babies.
Oct 25, 2022
0
39
The Phase II results of the NRG Oncology HN004 trial indicate that radiotherapy (RT) with the PD-L1 inhibitor durvalumab did not improve progression-free survival (PFS) and led to significantly higher rates of locoregional ...
Oct 24, 2022
0
69
Numerous studies have shown that drugs called immune checkpoint inhibitors can boost the immune system's response against various cancers. Now a phase II clinical trial has demonstrated that patients with a serious form of ...
Oct 24, 2022
0
63
Respiratory syncytial virus (RSV), a virus that can cause severe problems, especially for young children and older adults, has increased illness and hospitalizations.
Oct 14, 2022
0
39
The microenvironment surrounding tumors in HER2+ breast cancer protects them and helps them develop resistance to the most widely used treatment, the monoclonal antibody trastuzumab. And a particular type of cell in this ...
Oct 14, 2022
0
80
A new genetically engineered virus has delivered a one-two punch against advanced cancers in initial findings from a phase I trial.
Sep 23, 2022
0
3410